• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update

    Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 2nd Update

  2. Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update

    Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke -- 3rd Update

  3. UPDATE: 10 best, 10 worst stocks in the eight-year bull market

    UPDATE: 10 best, 10 worst stocks in the eight-year bull market

  4. UPDATE: 10 best, 10 worst stocks in the eight-year bull market

    UPDATE: 10 best, 10 worst stocks in the eight-year bull market

  5. Facing Criticism, Drug Makers Keep Lid On Price Increases

    Facing Criticism, Drug Makers Keep Lid On Price Increases

  6. The Year is U.S. Equity Funds

    Domestic stocks have proved resilient in a tumultuous 2016.

  7. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  8. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  9. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

123

©2017 Morningstar Advisor. All right reserved.